• Home
  • Contact
  • EnglishEnglish
    • DeutschDeutsch
Prof. Marcus Maurer
  • Personal Background
  • Publications
  • Research
Select Page
Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study

Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study

by admin | Jun 1, 2021

Omalizumab (Xolair®) is a recombinant humanized monoclonal anti-IgE antibody, which binds to free IgE, lowers free IgE levels, and causes FcεRI receptors on basophils and mast cells to be downregu-lated. Omalizumab is the first drug approved as an add-on therapy for...
Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study

The chronic urticaria registry: rationale, methods, and initial implementation

by admin | May 31, 2021

Background Chronic urticaria (CU) is a common disease, characterized by the recurrent appearance of wheals, angioedema or both for more than 6 weeks. Its underlying biology is not well understood, and many patients do not obtain sufficient relief from recommended...
Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

by admin | May 31, 2021

Introduction: The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown. Aim: To understand how CU patients are affected by the COVID-19 pandemic; how...
Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study

Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria

by admin | May 31, 2021

Purpose: Patients with chronic spontaneous urticaria (CSU) have an increased risk for comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we evaluated clinical and laboratory features of CSU associated with a higher risk of comorbid...
Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both

by admin | Mar 17, 2021

Background: Chronic urticaria (CU) is a common skin disorder, which can be further divided into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). Omalizumab is effective and safe for difficult-to-treat CSU based on clinical trials. However,...
« Older Entries

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Privacy Policy
    • Imprint
    • Cookie Policy (EU)
    © 2020 Marcus Maurer
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}